Liquidia Technologies (LQDA) Competitors $22.77 -1.00 (-4.21%) Closing price 04:00 PM EasternExtended Trading$23.12 +0.36 (+1.56%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. STVN, IRTC, BLCO, GKOS, TMDX, NVST, SLNO, LIVN, WRBY, and EYEShould you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), and National Vision (EYE). These companies are all part of the "medical equipment" industry. Liquidia Technologies vs. Its Competitors Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group Envista Soleno Therapeutics LivaNova Warby Parker National Vision Liquidia Technologies (NASDAQ:LQDA) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Which has higher valuation and earnings, LQDA or STVN? Stevanato Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia Technologies$14M140.02-$130.39M-$1.70-13.39Stevanato Group€1.19B6.13€127.45M€0.5444.80 Is LQDA or STVN more profitable? Stevanato Group has a net margin of 11.73% compared to Liquidia Technologies' net margin of -732.17%. Stevanato Group's return on equity of 10.34% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Liquidia Technologies-732.17% -232.96% -60.81% Stevanato Group 11.73%10.34%6.21% Do institutionals and insiders believe in LQDA or STVN? 64.5% of Liquidia Technologies shares are owned by institutional investors. 30.1% of Liquidia Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor LQDA or STVN? In the previous week, Liquidia Technologies had 1 more articles in the media than Stevanato Group. MarketBeat recorded 6 mentions for Liquidia Technologies and 5 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.75 beat Liquidia Technologies' score of 0.34 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Liquidia Technologies 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Stevanato Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, LQDA or STVN? Liquidia Technologies has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Do analysts prefer LQDA or STVN? Liquidia Technologies currently has a consensus target price of $32.38, indicating a potential upside of 42.18%. Given Liquidia Technologies' higher possible upside, equities research analysts clearly believe Liquidia Technologies is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia Technologies 2 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.70Stevanato Group 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.71 SummaryStevanato Group beats Liquidia Technologies on 10 of the 16 factors compared between the two stocks. Get Liquidia Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.96B$3.36B$6.02B$10.45BDividend YieldN/A2.31%5.73%4.82%P/E Ratio-13.3922.0385.1227.24Price / Sales140.02472.74589.92133.47Price / CashN/A44.9825.7730.18Price / Book25.0210.4312.676.76Net Income-$130.39M-$52.58M$3.32B$276.59M7 Day Performance-5.20%0.98%0.50%0.86%1 Month Performance-12.39%14.76%9.42%8.17%1 Year Performance104.49%21.29%79.11%43.66% Liquidia Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia Technologies3.2787 of 5 stars$22.77-4.2%$32.38+42.2%+114.4%$1.96B$14M-13.3950STVNStevanato GroupN/A€24.57-5.4%N/A+22.8%€7.44B€1.19B45.505,521IRTCiRhythm Technologies1.2788 of 5 stars$175.74+0.1%$172.17-2.0%+210.8%$5.64B$657.23M-59.982,000Analyst ForecastBLCOBausch + Lomb1.5378 of 5 stars$14.87-2.2%$15.60+4.9%-23.6%$5.38B$4.79B-19.0613,500GKOSGlaukos4.3269 of 5 stars$86.64-0.9%$122.00+40.8%-34.5%$5.01B$383.48M-52.51780Analyst ForecastTMDXTransMedics Group3.3633 of 5 stars$113.93-1.5%$125.40+10.1%-17.4%$3.94B$441.54M59.03210News CoveragePositive NewsAnalyst ForecastNVSTEnvista3.97 of 5 stars$20.64-1.0%$20.92+1.4%+6.1%$3.46B$2.51B64.5012,300SLNOSoleno Therapeutics4.3937 of 5 stars$58.45-1.3%$115.09+96.9%+17.4%$3.15B$32.66M-14.1230LIVNLivaNova2.216 of 5 stars$52.63-1.4%$59.71+13.5%-1.4%$2.91B$1.25B-13.532,900WRBYWarby Parker2.3444 of 5 stars$25.41-3.1%$24.75-2.6%+40.7%$2.76B$771.32M-362.953,780Positive NewsEYENational Vision2.1565 of 5 stars$28.15-2.5%$24.73-12.2%+162.6%$2.29B$1.89B-156.3913,411Positive News Related Companies and Tools Related Companies Stevanato Group Competitors iRhythm Technologies Competitors Bausch + Lomb Competitors Glaukos Competitors TransMedics Group Competitors Envista Competitors Soleno Therapeutics Competitors LivaNova Competitors Warby Parker Competitors National Vision Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
